Novonesis Statistics
Total Valuation
Novonesis has a market cap or net worth of EUR 25.22 billion. The enterprise value is 26.74 billion.
Market Cap | 25.22B |
Enterprise Value | 26.74B |
Important Dates
The next estimated earnings date is Thursday, May 8, 2025.
Earnings Date | May 8, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 347.12M |
Valuation Ratios
The trailing PE ratio is 82.49.
PE Ratio | 82.49 |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | 21.90 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 24.80, with an EV/FCF ratio of 39.23.
EV / Earnings | 87.44 |
EV / Sales | 6.98 |
EV / EBITDA | 24.80 |
EV / EBIT | 31.87 |
EV / FCF | 39.23 |
Financial Position
The company has a current ratio of 1.73, with a Debt / Equity ratio of 0.16.
Current Ratio | 1.73 |
Quick Ratio | 1.05 |
Debt / Equity | 0.16 |
Debt / EBITDA | 1.66 |
Debt / FCF | 2.64 |
Interest Coverage | 10.48 |
Financial Efficiency
Return on equity (ROE) is 4.67% and return on invested capital (ROIC) is 6.61%.
Return on Equity (ROE) | 4.67% |
Return on Assets (ROA) | 5.54% |
Return on Invested Capital (ROIC) | 6.61% |
Return on Capital Employed (ROCE) | 5.97% |
Revenue Per Employee | 362,266 |
Profits Per Employee | 28,898 |
Employee Count | 10,582 |
Asset Turnover | 0.40 |
Inventory Turnover | 3.05 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.72% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -1.72% |
50-Day Moving Average | 54.86 |
200-Day Moving Average | 57.35 |
Relative Strength Index (RSI) | 47.53 |
Average Volume (20 Days) | 27 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novonesis had revenue of EUR 3.83 billion and earned 305.80 million in profits. Earnings per share was 1.10.
Revenue | 3.83B |
Gross Profit | 1.99B |
Operating Income | 842.90M |
Pretax Income | 417.10M |
Net Income | 305.80M |
EBITDA | 1.08B |
EBIT | 842.90M |
Earnings Per Share (EPS) | 1.10 |
Balance Sheet
The company has 280.00 million in cash and 1.80 billion in debt, giving a net cash position of -1.52 billion.
Cash & Cash Equivalents | 280.00M |
Total Debt | 1.80B |
Net Cash | -1.52B |
Net Cash Per Share | n/a |
Equity (Book Value) | 11.18B |
Book Value Per Share | 40.22 |
Working Capital | 791.10M |
Cash Flow
In the last 12 months, operating cash flow was 1.02 billion and capital expenditures -338.30 million, giving a free cash flow of 681.60 million.
Operating Cash Flow | 1.02B |
Capital Expenditures | -338.30M |
Free Cash Flow | 681.60M |
FCF Per Share | n/a |
Margins
Gross margin is 52.00%, with operating and profit margins of 21.99% and 7.98%.
Gross Margin | 52.00% |
Operating Margin | 21.99% |
Pretax Margin | 10.88% |
Profit Margin | 7.98% |
EBITDA Margin | 28.23% |
EBIT Margin | 21.99% |
FCF Margin | 17.78% |
Dividends & Yields
This stock pays an annual dividend of 0.54, which amounts to a dividend yield of 1.00%.
Dividend Per Share | 0.54 |
Dividend Yield | 1.00% |
Dividend Growth (YoY) | -60.83% |
Years of Dividend Growth | n/a |
Payout Ratio | 81.65% |
Buyback Yield | -0.64% |
Shareholder Yield | 0.36% |
Earnings Yield | 1.21% |
FCF Yield | 2.70% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Novonesis has an Altman Z-Score of 5.27.
Altman Z-Score | 5.27 |
Piotroski F-Score | n/a |